EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

ANALYSIS OF THE PATTERN OF ADVERSE DRUG REACTIONS AT A TERTIARY CARE HOSPITAL: A CROSS-SECTIONAL STUDY

Virendra Kushwaha*, Pooja Agrawal, Anuj Kumar, Pradeep Kumar, BK Shoraisham and Sarthak Goel

ABSTRACT

Background: Adverse drug reaction (ADR) contributes to drug-related morbidity and mortality, and increases the economic burden of the country. It is important to monitor the effects of drugs, both intended and unwanted, to get an evidence-based assessment of risk / benefit ratio. Today it is well recognized that a reliable Pharmacovigilance system is essential for rational, safe and cost-effective use of medicines and therefore has clear advantages in relation to cost for public health. Aims and Objectives: Evaluation of ADRs in various departments of a tertiary care government hospital. Methodology: A cross-sectional observational study was carried out for a duration of 4 weeks from 16 February 2023 to 15 March 2023. The ADRs were reported from patients attending out-patient department (OPD) and in-patient department (IPD), LLR Hospital of GSVM Medical college. ADR data was collected in a suspected ADR reporting form. Result: During the study period a total of 270 patients were observed in which 107 patients (39.62%) reported ADRs from different departments. Most of the patients were between 21 to 40 years old with male preponderance. The majority of ADRs are of Type–-A (81.30%) while the remaining are of Type-B (15.88%) and Type-C (2.80%). The most frequently involved organ system was GIT (28.97%) followed by CNS, Skin, Renal, Respiratory, CVS, and others. Conclusion: From the study, we conclude that most of the ADRs of type-A of mild severity and preventable, and GIT is the most common system affected. Careful attention is needed in monitoring and reporting of ADR‟s.

Keywords: ADR, OPD, IPD, Pharmacovigilance.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 May 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MAY ISSUE PUBLISHED

    MAY 2024 issue has been successfully launched on MAY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia